March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low dose ...
March 23, 2017
Feature | Heart Valve Technology
March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic valve ...
March 23, 2017
News | Pharmaceuticals
In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when given on top of effective statin therapy, had widely varying effects on LDL cholesterol levels and had no benefit on cardiovascular events among those with LDL lower than 100 mg/dL. However, in patients at high cardiovascular risk who had baseline LDL of greater than 100 mg/dL, bococizumab significantly reduced the risk of cardiovascular events by 21 percent compared with placebo, according to research presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.
March 22, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Pacemakers
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing ...
March 22, 2017
Feature | Embolic Protection Devices
March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove ...
March 22, 2017
Technology | Left Atrial Appendage (LAA) Occluders
Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial in the U.S. for its Sierra Ligation System medical device. Aegis developed the Sierra technology in partnership with the Mayo Clinic in Rochester, Minn. Sierra could, with additional clinical research, prove to prevent stroke in patients with atrial fibrillation (AF), according to the company.
March 22, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | ACC
Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presented ...
March 22, 2017
Feature | Heart Valve Technology
March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve ...
March 22, 2017
News | Computed Tomography (CT)
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FIRST ...
March 21, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Advanced Visualization
March 21, 2017 — EchoPixel recently announced progress in the clinical adoption of its True 3D virtual reality software ...
March 21, 2017
Videos | Hemodynamic Support Devices
This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers ...
March 21, 2017
Feature | Heart Valve Technology
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...
March 21, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Cardiac Diagnostics
March 21, 2017 — A blood test for a protein called high-sensitivity troponin T, which is released into the bloodstream ...
March 21, 2017
Feature | Stents Bioresorbable | Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...
March 21, 2017Technology | Guidewires
March 20, 2017 — Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U ...
March 20, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now